This pronounced difference in the effect of GPR18 deletion on contractile signaling between large elastic and muscular-type arteries would suggest that targeting hypercontractility in arterial diseases through GPR18 signaling would be most effective in cardiovascular diseases that primarily affect large elastic arteries (e.g., systolic hypertension, arterial stiffening). Here, GPR18 is linked to arterial disorder.